Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Xalkori: A Revolution in Lung Cancer Treatment

August 30th 2011

While smoking and lung cancer have always been closely linked, recent advances in research have begun to unravel the genetic code behind the disease.

Dr. Li Discusses ALK Gene Mutation Tests

August 29th 2011

Dr. Tianhong (Tina) Li from UC Davic Cancer Center Discusses ALK Gene Mutation Tests

FDA Approves Crizotinib for Late-Stage Non-Small Cell Lung Cancer

August 26th 2011

On Friday, August 26, 2011, the FDA approved crizotinib (Xalkori) to treat ALK-positive patients with late-stage non–small cell lung cancer (NSCLC).

Dr. Yoneda on Advances in the Diagnosis of Lung Cancer

August 26th 2011

Dr. Ken Y. Yoneda from UC Davis Cancer Center on Advances in the Diagnosis of Lung Cancer

ASCO 2011: What Nurses Need to Know

August 26th 2011

Personal perspectives from oncology nurses of abstracts presented at ASCO on research with the potential to change practice, important studies that failed to meet expectations, and topics particularly relevant to oncology nurses.

Dr. Reckamp Discusses the Use of Hsp90 Inhibitors

August 25th 2011

Dr. Karen Reckamp from the City of Hope Cancer Center Discusses the Use of Hsp90 Inhibitors

Dr. Yoneda on Bronchoscopy Tools and Procedures

August 24th 2011

Dr. Ken Yoneda from UC Davis Cancer Center Discusses Bronchoscopy Tools and Procedures

ASCO Highlights: Trials in Progress

August 23rd 2011

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.

Dr. Reckamp on Current Heat Shock Protein Clinical Trials

August 22nd 2011

Dr. Karen Reckamp City of Hope cancer center on Current Heat Shock Protein Clinical Trials

Dr. Yoneda Discusses the Role of the Pulmonologist

August 19th 2011

Dr. Ken Yoneda from UC Davis Cancer Center Discusses the Role of the Pulmonologist

Dr. Reckamp Describes the Use of Heat Shock Proteins

August 19th 2011

Dr. Karen Reckamp from City of Hope Cancer Center Describes the Use of Heat Shock Proteins

Dr. Reckamp Discusses Heat Shock Proteins in Lung Cancer

August 17th 2011

Dr. Karen Reckamp from City of Hope Cancer center Discusses Heat Shock Proteins in Lung Cancer

Dr. Herbst on the 2011 Lung Cancer Congress Themes

August 10th 2011

Dr. Roy S. Herbst from Yale Comprehensive Cancer Center on Themes From the 2011 Lung Cancer Congress

Dr. Kris Discusses Available Targeted Therapies

August 10th 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses Available Targeted Therapies

Dr. Herbst on the International Lung Cancer Congress

August 9th 2011

Dr. Roy S. Herbst from Yale comprehensive cancer center on the International Lung Cancer Congress

Dr. Herbst on the 2011 Lung Cancer Congress Topics

August 8th 2011

Dr. Roy Herbst from the Yale Comprehensive Cancer Center on Screening Studies at the Upcoming Lung Cancer Congress

Weighing the Risk Versus Benefits of Transthoracic Needle Biopsies in Lung Cancer

August 2nd 2011

A new study found that biopsies of lung nodules found during a CT scan may be unnecessary and dangerous.

Dr. Kris on Patient Acceptance of Mutation Testing

August 2nd 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses Patient Acceptance of Mutation Testing

Study Finds Erlotinib Superior to Conventional Chemotherapy in Treatment of EGFR-Mutated Advanced NSCLC

August 2nd 2011

PFS improved significantly in patients with EGFR-mutated advanced NSCLC treated first line with erlotinib versus platinum-based chemotherapy.

Dr. West Discusses Anticipated Future Clinical Trials

August 1st 2011

Dr. Jack West from the Swedish Cancer Institute Talks About Anticipated Future Clinical Trials

NEXT PAGE
PREVIOUS PAGE